Antibiotic resistance is quietly becoming one of the world’s most dangerous health threats not because treatments don’t exist, but because the first antibiotic decision is often a blind guess. In emergency wards and rural clinics, doctors are forced to prescribe antibiotics before lab reports arrive. A single wrong first choice can fail the patient and accelerate long-term antibiotic resistance.
MEDIXA addresses this critical gap by acting as an explainable clinical decision-support system that predicts the risk of antibiotic failure before prescription. Instead of recommending drugs, the system evaluates whether the selected antibiotic is likely to fail for a specific patient.Using patient history, infection context, prior antibiotic exposure, and local resistance trends, the model frames the problem as an explainable binary classification task (Low-Risk vs High-Risk). High-risk prescriptions are flagged in advance with clear, human-readable explanations, allowing doctors to reconsider, monitor closely, or confirm with diagnostics—while maintaining full clinical control.Designed for daily use in high-pressure, resource-limited settings, 1features a secure login, a clean dashboard, and minimal data entry to ensure practicality. Alerts are triggered only for high-risk cases, avoiding alert fatigue and unnecessary interruptions.
The core innovation lies in risk prediction, not prescription automation. By supporting clinical judgment rather than replacing it reduces guesswork at the most critical moment—the first dose. This early-warning approach improves first-line treatment decisions, reduces unnecessary antibiotic misuse, and helps slow antibiotic resistance before the damage is done, not after.
"Helping doctors prioritize, predict, and decide without replacing them"